- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07946146
A Single-Center, Prospective Clinical Cohort Study on Perioperative Management, Exposure, Multiorgan Outcomes, and Functional Recovery in Liver Transplantation
The objective of this observational study (a single-center, prospective, consecutively enrolled clinical cohort) is to establish a cohort of adult liver transplant recipients to correlate, within the same population, the recipients' preoperative status with graft condition, perioperative medical and therapeutic exposures, and dynamic physiological changes, as well as multiorgan outcomes and functional recovery; to identify factors associated with organ injury and difficulties in recovery; and to provide a basis for subsequent clinical validation and intervention studies. The study population consists of adult recipients aged ≥18 years who are scheduled to undergo their first single-liver transplant at this center; continuous enrollment is planned for 5 years, with a target of 450 participants, each followed for 12 months. Recipients undergoing repeat liver transplantation or combined organ transplantation will be included only in a separate expanded registry and analysis.
The primary research questions it aims to address are:
What is the incidence rate and 95% confidence interval of the patient-level composite outcome-defined as all-cause mortality or at least one of the predefined major organ complications (early graft dysfunction/graft failure, new-onset or worsening moderate-to-severe acute kidney injury, new-onset delirium or confirmed acute neurological event, major cardiovascular event, or major pulmonary complication)-within 30 days after the start of the transplant procedure? After accounting for preoperative disease severity, organ function, and graft condition, how are perioperative clinical exposures and physiological changes-such as circulatory, respiratory, temperature, and EEG parameters-associated with multiorgan outcomes and functional recovery at 12 months? Can prespecified dynamic physiological data provide additional information regarding risk or recovery beyond routine clinical data?
This study has no control group; no treatment will be assigned; routine monitoring, testing, or rehabilitation arrangements will not be altered; and no additional blood draws or tissue samples will be collected. Participants will:
Undergo preoperative baseline data collection and assessments of cognition, frailty, functional status, and quality of recovery; some participants will complete the sleep and mood extension modules (PSQI, HADS).
During the perioperative period, participants will allow the research team to record clinically generated treatment exposures and multimodal monitoring data, including circulatory, respiratory, temperature, and EEG parameters.
Participants will complete relevant follow-up visits and functional assessments on postoperative days 7, 30, and 90, as well as at 6 and 12 months, including the QoR-15, DAH-30/90, and assessments of cognition, frailty, functional status, and quality of life.
Follow-up should preferably be conducted in conjunction with routine follow-up visits; when necessary, survival, hospitalization, and living conditions may be verified via approved telephone contact. Additional clinical testing using residual serum and tissue samples is optional; refusal to provide these samples will not affect enrollment in the study.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Yi Duan, Master's Degree
- Telefonnummer: +86 13810385311
- E-post: Dya01610@btch.edu.cn
Studiesteder
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina, 102218
- Rekruttering
- Beijing Tsinghua Changgung Hospital
-
Ta kontakt med:
- Yi Duan, Master's Degree
- Telefonnummer: +86 13810385311
- E-post: Dya01610@btch.edu.cn
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
This is a single-center study, and the study population is sourced from Beijing Tsinghua Changgung Hospital. Adult recipients (aged ≥18 years) scheduled to undergo primary single liver transplantation at this center are consecutively screened during waitlist registration, inpatient preoperative evaluation, or pre-transplant preparation. With an estimated 100 adult liver transplant surgeries performed annually at this center, approximately 450 recipients are planned to be enrolled consecutively over a 5-year period.
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years.
- Scheduled to undergo primary single liver transplantation at this center.
- The participant or legally authorized representative has completed the ethically approved informed consent process.
(Note: Patients undergoing emergency transplantation, preoperative hepatic encephalopathy, intensive care, mechanical ventilation, and renal replacement therapy are eligible. Donor type and disease severity will be retained as stratification information.)
Exclusion Criteria:
- Age < 18 years.
- History of previous liver transplantation.
- This surgery is a combined organ transplantation.
- Refusal to participate.
- Unable to complete valid authorization under the informed consent procedure approved for this study.
(Note: Patients undergoing re-transplantation and combined organ transplantation may enter a separate extended registry within the same ethical framework, but will not be mixed into the primary analysis cohort of primary single liver transplantation and its sample size denominator.)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Number of participants with all-cause mortality or at least one major organ complication within 30 days after the start of transplant surgery, assessed according to preset clinical criteria (e.g., Olthoff definition, KDIGO criteria).
Tidsramme: From the start of surgery to 30 days postoperatively.
|
From the start of surgery to 30 days postoperatively.
|
Samarbeidspartnere og etterforskere
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Cywinski JB, Li Y, Liu X, Khanna S, Irefin S, Mousa A, Maheshwari K. Intraoperative hypotension during liver transplantation and postoperative outcomes: Retrospective cohort study. J Clin Anesth. 2024 Sep;96:111486. doi: 10.1016/j.jclinane.2024.111486. Epub 2024 May 9.
- Puchades L, Herreras J, Cebria I Iranzo MA, Reyes E, Crespo G, Rodriguez-Peralvarez M, Cortes L, Serrano T, Fernandez-Yunquera A, Montalva E, Berenguer M. Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study. Transplant Direct. 2024 Mar 22;10(4):e1599. doi: 10.1097/TXD.0000000000001599. eCollection 2024 Apr.
- Pollok JM, Tinguely P, Berenguer M, Niemann CU, Raptis DA, Spiro M; ERAS4OLT.org collaborative. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):81-94. doi: 10.1016/S2468-1253(22)00268-0.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 27410-4-01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .